Bridged Bicyclo Compounds, Heterocyclic < Bromocriptine < Bromodeoxyuridine

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000479 (2014)	Thomas Cautres [France] ; Michel Cautres [France] ; Dania Mohty [France]	Multiple valvular regurgitation associated with bromocriptine therapy.
000563 (2014)	Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]	Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.
000B69 (2009)	Joëlle Micallef [France] ; Marc Rey ; Alexandre Eusebio ; Christine Audebert ; Frank Rouby ; Elisabeth Jouve ; Sophie Tardieu ; Oliver Blin	Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
000B96 (2009)	Sarah Vautier [France] ; Aline Milane ; Christine Fernandez ; Helene Chacun ; Lucette Lacomblez ; Robert Farinotti	Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
000E53 (2006)	Djamel Ben Smaïl [France] ; Christiane Samuel ; Karine Rouy-Thenaisy ; Joelle Régnault ; Philippe Azouvi	Bromocriptine in traumatic brain injury.
000F17 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
001118 (????)	Jacques Serratrice [France] ; Patrick Disdier ; Gilbert Habib ; François Viallet ; Pierre-Jean Weiller	Fibrotic valvular heart disease subsequent to bromocriptine treatment.
001210 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
001243 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
001328 (1999)	S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M Davy	Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
001339 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
001433 (1998)		Ropinirole: new preparation. Wait for more convincing data.
001463 (1997)	J M Senard [France] ; S. Raï ; M. Lapeyre-Mestre ; C. Brefel ; O. Rascol ; A. Rascol ; J L Montastruc	Prevalence of orthostatic hypotension in Parkinson's disease.
001525 (1996)	J L Montastruc [France] ; O. Rascol ; J M Senard	New directions in the drug treatment of Parkinson's disease.
001526 (1996)	F. Picard [France] ; A. De Saint-Martin ; E. Salmon ; E. Hirsch ; C. Marescaux	Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
001540 (1996)	P. Limousin [France] ; P. Pollak ; D. Hoffmann ; A. Benazzouz ; J E Perret ; A L Benabid	Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
001581 (1995)	A M Bonnet [France] ; I. Serre ; R. Marconi ; Y. Agid ; B. Dubois	A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
001624 (1994)	J L Montastruc [France] ; O. Rascol ; J M Senard ; A. Rascol	A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
001632 (1994)	O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. Rascol	Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
001672 (1993)	L. Rumbach [France] ; C. Tranchant ; J F Viel ; J M Warter	Event-related potentials in Parkinson's disease: a 12-month follow-up study.
001718 (1992)	G. Durrieu [France] ; M E Llau ; O. Rascol ; J M Senard ; A. Rascol ; J L Montastruc	Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Bromocriptine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024